510(k) Report

510(k) · Cleared

Cleared

Terumo 31G Thinpro Insulin Syringe

K071630510(k) SpecialCleared Jul 11, 200727-day reviewClass II21 CFR 880.5860

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Terumo Medical Corp. · FMF Syringe, Piston

Cleared on Jul 11, 2007 as substantially equivalent to K822083 (Terumo Medical Corp., 1982) and 3 other predicates after a 27-day review. Its family tree reaches back 2 generations to 1982. 82 later devices descend from it.

Decided
Jul 11, 2007
Review
27 days
Class
Class II
Product code
FMF
Recalls
None
Predicates
4

Its longest line of descent runs back 2 generations to K822083 (1982). 4 ancestors in all. 82 later devices descend from it, 3 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2000: 1 other ancestor1996: 1 other ancestor2017: 5 descendants cleared2008: 1 descendant cleared2009: 1 descendant cleared2016: 3 descendants cleared2011: 4 descendants cleared2018: 3 descendants cleared2015: 1 descendant cleared2021: 13 descendants cleared2013: 1 descendant cleared2012: 1 descendant cleared2023: 15 descendants cleared2019: 2 descendants cleared2022: 13 descendants cleared2020: 4 descendants cleared2024: 6 descendants cleared2025: 6 descendants cleared2026: 3 descendants clearedK822083 · U-100 Insulin Syringe · Terumo Medical Corp. · 1982K992802 · Terumo U-100 Insulin Syringe · Terumo Medical Corp. · 199919801990200020102020
Other ancestors, by generationDescendants, by generation 1 generation back: 2 other ancestors 1 generation forward: 3 descendants2 generations forward: 12 descendants3 generations forward: 24 descendants4 generations forward: 30 descendants5 generations forward: 9 descendants6 generations forward: 3 descendants7 generations forward: 1 descendant K992802 · Terumo U-100 Insulin Syringe · Terumo Medical Corp. · 1999K822083 · U-100 Insulin Syringe · Terumo Medical Corp. · 19820+5
  1. Root · 2 generations backK822083 U-100 Insulin SyringeTerumo Medical Corp. · 1982
  2. 1 generation backK992802 Terumo U-100 Insulin SyringeTerumo Medical Corp. · 1999
  3. This deviceK071630 Terumo 31G Thinpro Insulin SyringeTerumo Medical Corp. · 2007
  4. Descendant · cites it directly · 78 of its ownK072739 Jierui Syringes and NeedlesShandong Weigao Group Medical Polymer Co., Ltd. · 2008
  5. Descendant · 2 generations on · 36 of its ownK110421 Disposable Insulin SyringeWenzhou Wuzhou Import & Export Co., Ltd. · 2011
  6. Descendant · 2 generations on · 31 of its ownK112057 KDL Syringes and NeedleShanghai Kindly Enterprise Dev. Group Co., · 2011
  7. Descendant · 3 generations on · 13 of its ownK190002 Sterile Hypodermic Syringe for Single use, with/without needle…Shanghai Kohope Medical Devices Co., Ltd. · 2019
  8. Descendant · 2 generations on · 12 of its ownK180417 Self-destruction Safety Syringes for Single Use; Sterile Hypodermic…Berpu Medical Technology Co., Ltd. · 2018

Showing 5 of 82 descendants. See all descendants

Descendants cleared per year

2008: 12009: 12011: 42012: 12013: 12015: 12016: 32017: 52018: 32019: 22020: 42021: 132022: 132023: 152024: 62025: 62026: 3
2008high 15 (2023) · low 0 (2010)2026

Most influential descendants

Showing 5 of 82 · See all
  • K072739Jierui Syringes and NeedlesShandong Weigao Group Medical Polymer Co., Ltd. · 2008 · cites it directly78descendants
  • K110421Disposable Insulin SyringeWenzhou Wuzhou Import & Export Co., Ltd. · 2011 · 2 generations on36descendants
  • K112057KDL Syringes and NeedleShanghai Kindly Enterprise Dev. Group Co., · 2011 · 2 generations on31descendants
  • K190002Sterile Hypodermic Syringe for Single use, with/without needle, Sterile Insulin Syringe…Shanghai Kohope Medical Devices Co., Ltd. · 2019 · 3 generations on13descendants
  • K180417Self-destruction Safety Syringes for Single Use; Sterile Hypodermic Syringes for Single…Berpu Medical Technology Co., Ltd. · 2018 · 2 generations on12descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K822083U-100 Insulin SyringeTerumo Medical Corp.1982—
−1K992802Terumo U-100 Insulin SyringeTerumo Medical Corp.1999—
0 (this device)K071630Terumo 31G Thinpro Insulin SyringeTerumo Medical Corp.2007—
+1K072739Jierui Syringes and NeedlesShandong Weigao Group Medical Polymer Co., Ltd.2008—
+2K110421Disposable Insulin SyringeWenzhou Wuzhou Import & Export Co., Ltd.2011—
+2K112057KDL Syringes and NeedleShanghai Kindly Enterprise Dev. Group Co.,2011—
+3K190002Sterile Hypodermic Syringe for Single use, with/without needle, Sterile…Shanghai Kohope Medical Devices Co., Ltd.2019—
+2K180417Self-destruction Safety Syringes for Single Use; Sterile Hypodermic Syringes…Berpu Medical Technology Co., Ltd.2018—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199610
200010

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200810
200910
201140
201210
201310
201510
201630
201750
201830
201920
202040
2021130
2022130
2023150
202460
202560
202630
FIG. 1 — Lineage of K071630, 1982–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FMF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FMF device

  1. #1 K241821 Luer Lock Syringe with Safety Needle; Luer…score 16.2 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (4)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K822083U-100 Insulin Syringe
Summary page 1
…ubstantially equivalent in intended use, design, technology/principles of operation, materials and performance to the cleared TERUMO®k Insulin Syringe (K822083, K992802, & KOO 1474 -Pediatric Indication) and the Becton Dickinson® Ultra-Fine TM II Insulin Syringe (K955235). PRIN…
Terumo Medical Corp.1982—
*K992802Terumo U-100 Insulin Syringe
Summary page 1
…lly equivalent in intended use, design, technology/principles of operation, materials and performance to the cleared TERUMO®k Insulin Syringe (K822083, K992802, & KOO 1474 -Pediatric Indication) and the Becton Dickinson® Ultra-Fine TM II Insulin Syringe (K955235). PRINCIPLE OF…
Terumo Medical Corp.1999—
*K001474Terumo U-100 Insulin Syring
Summary page 1
…device is operated manually. MATERIALS The materials used in this device are the same as used in the TERIJMO® Insulin Syringe (K822083 , K992802, & K00 1474 - Pediatric Indication>- 09 C~…
Terumo Medical Corp.2000—
*K955235B-D Ultra Fine II, Micro Fine + Short Needle Insulin Syringe
Summary page 1
…o the cleared TERUMO®k Insulin Syringe (K822083, K992802, & KOO 1474 -Pediatric Indication) and the Becton Dickinson® Ultra-Fine TM II Insulin Syringe (K955235). PRINCIPLE OF OPERATION/TECHNOLOGY This device is operated manually. MATERIALS The materials used in thi…
Bd Becton Dickinson Vacutainer Systems Preanalytic19961

Also cleared against K822083: 3 other devices →

What descends from it? (82)

See all 82

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K072739Jierui Syringes and NeedlesShandong Weigao Group Medical Polymer Co., Ltd.200878
K090929Sterile Hypodermic Syringe and Needle for Single Use, Sterile Insuling Syringe for…Shanghai Double Dove Industrial Co., Ltd.20091
K160589Certa Dose PD Epinephrine 1mg/mL IM/SC SyringeCerta Dose, Inc.20170

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 25 years and passes through 1 company; a new generation was cleared every 17.1 years on median.
  • 1 of the 4 ancestors has a recall of any class.
  • Of its descendants, K072739 (Shandong Weigao Group Medical Polymer Co., Ltd., 2008) has gone furthest, with 78 descendants of its own.
  • 3 other devices also cite its predicate K822083.

How does its category compare?

All FMF devices

FMF Syringe, Piston: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · FMF

13in 2025

2007: 232008: 92009: 142010: 112011: 162012: 92013: 122014: 132015: 112016: 122017: 132018: 82019: 112020: 152021: 202022: 242023: 222024: 142025: 132026 (partial year): 9
2007high 24 (2022) · low 8 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FMF

114in 2025

2007: 90 days median2008: 74 days median2009: 94 days median2010: 130 days median2011: 109 days median2012: 86 days median2013: 154 days median2014: 84 days median2015: 87 days median2016: 146 days median2017: 135 days median2018: 87 days median2019: 146 days median2020: 107 days median2021: 175 days median2022: 211 days median2023: 173 days median2024: 130 days median2025: 114 days median2026 (partial year): 239 days median
2007high 239 (2026) · low 74 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FMF

19in 2023

2007: 62008: 112009: 152010: 122011: 32012: 62013: 12014: 12015: 22017: 32018: 22019: 12020: 22021: 12022: 22023: 19, 18 Class I2026 (partial year): 2, 1 Class I
2007high 19 (2023) · low 0 (2016)2026

Class I (19 since 2007) Class II/III not classified

Adverse event reports per year · FMF

4,181in 2025

2007: 6742008: 6912009: 9132010: 6792011: 1862012: 3072013: 3262014: 2442015: 2732016: 6842017: 1,8582018: 3,9522019: 5,8632020: 5,3342021: 5,8742022: 5,2332023: 5,2142024: 5,1222025: 4,181
2007high 5,874 (2021) · low 186 (2011)2025

MAUDE reports naming product code FMF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200723906674
200897411691
2009149415913
20101113012679
2011161093186
20129866307
2013121541326
201413841244
201511872273
2016121460684
20171313531,858
201888723,952
20191114615,863
20201510725,334
20212017515,874
20222421125,233
20232217319 (18)5,214
20241413005,122
20251311404,181
202692392 (1)—

What is it indicated for?

The TERUMO® 31G ThinPro Insulin Syringe, with fixed hypodermic single lumen needle, is a device intended for medical purposes for the manual aspiration of fluids, and for the injection of fluids into parts of the body below the surface of the skin. This device is intended particularly for the aspiration and injection of insulin. This syringe with 31G needle is indicated for general use and for pediatric patients.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K071630: Terumo 31G Thinpro Insulin Syringe.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K071630

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026